0000899243-21-013634.txt : 20210326 0000899243-21-013634.hdr.sgml : 20210326 20210326150141 ACCESSION NUMBER: 0000899243-21-013634 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210326 FILED AS OF DATE: 20210326 DATE AS OF CHANGE: 20210326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAO JOHN E CENTRAL INDEX KEY: 0001222028 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40295 FILM NUMBER: 21776786 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alignment Healthcare, Inc. CENTRAL INDEX KEY: 0001832466 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 465596242 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 W. TOWN AND COUNTRY ROAD STREET 2: SUITE 1600 CITY: ORANGE STATE: CA ZIP: 92868 BUSINESS PHONE: 844-310-2247 MAIL ADDRESS: STREET 1: 1100 W. TOWN AND COUNTRY ROAD STREET 2: SUITE 1600 CITY: ORANGE STATE: CA ZIP: 92868 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2021-03-26 0 0001832466 Alignment Healthcare, Inc. ALHC 0001222028 KAO JOHN E C/O ALIGNMENT HEALTHCARE, INC. 1100 W. TOWN & COUNTRY ROAD, SUITE 1600 ORANGE CA 92868 1 1 0 0 Chief Executive Officer Common Stock, par value $0.001 per share ("Common Stock") 4596067 I See Footnote Stock Option (right to buy) 18.00 2031-03-25 Common Stock 3916668 I See Footnote Represents 2,797,642 shares of Common Stock of Alignment Healthcare, Inc. (the "Company") and 1,487,395 restricted shares of Common Stock of the Company that will vest upon a change of control of the Company or otherwise (A) if received in exchange for pre-IPO (as defined below) transaction-based incentive units, on the later of (x) the four-year anniversary of the initial vesting date, or (y) 50% on the first anniversary of Company's initial public offering (the "IPO") and 50% on the second anniversary of the IPO, in each case, subject to Mr. Kao's continued employment or service on each such vesting date and (B) if received in exchange for pre-IPO service-based incentive units according to the pre-IPO vesting schedule applicable to Mr. Kao disclosed in the "Executive Compensation - Outstanding Equity Awards at Fiscal Year End" section of the Company's registration statement on Form S-1. Also represents 311,030 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on the first four anniversaries of the initial vesting date. Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Vest 25% on the first four anniversaries of the initial vesting date. Exhibit List - Exhibit 24.1 - Power of Attorney /s/ Richard A. Cross, as Attorney-in-Fact, for John E. Kao 2021-03-26 EX-24.1 2 attachment1.htm EX-24.1 DOCUMENT

                               POWER OF ATTORNEY

        KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and
appoints each of (i) R. Thomas Freeman, (ii) Michael C. Foster and (iii) Richard
A. Cross, signing SINGLY, the undersigned's true and lawful attorney-in-fact to:

        (1)  execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer, director or holder of 10% or more of the registered
class of securities of SOAR Technology Acquisition Corp. (the "Company"), Forms
3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of
1934, as amended, and the rules thereunder;

        (2)  do and perform any and all acts for and on behalf of the
undersigned that may be necessary or desirable to complete and execute any such
Form 3, 4 or 5, complete and execute any amendment or amendments thereto and
timely file such forms or amendments with the United States Securities and
Exchange Commission and any stock exchange or similar authority; and

        (3)  take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.

        The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.

        This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

                                   * * * * *

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 25 day of March 2021.

                                    By: /s/ John E. Kao
                                        ----------------------------
                                        Name: John E. Kao